CFO Moves this week include:
|Netflix Inc.||Activision Blizzard, Inc.||Square, Inc.|
|CIRCOR International, Inc.||Red Robin Gourmet Burgers, Inc.||Fiesta Restaurant Group, Inc.|
|Infogroup||Unum Therapeutics Inc.||Incyte|
|Southern Company||ImmusanT, Inc.||Mellanox Technologies, Ltd.|
|Cortexyme||PRGX Global, Inc.||BlueCrest|
|Marlin Business Services Corp.||Lattice Semiconductor Corporation||TELA Bio®, Inc.|
|Fortis Energy Services, Inc.||InnerWorkings, Inc.||TILT Holdings Inc.|
|Diebold Nixdorf||Unitil Corporation||REVA Medical, Inc.|
|Bio-Rad Laboratories, Inc.||Calyxt, Inc.||Livongo Health|
|IGM Biosciences, Inc.||AAR||Matinas BioPharma Holdings, Inc.|
|Pliant Therapeutics, Inc.||Arcturus Therapeutics Ltd.|
Would you like to receive our weekly CFO Moves directly in your email? Click the SIGN ME UP! button on the right of the blog page.
Should you have any CFO Moves to report, please email us.
NOTE: CFO Search Report available monthly to CFOs only. Read more here.
CFO Moves is published by Samuel Dergel (Executive Search Consultant and CFO & Financial Executive Search Specialist with Dergel Executive Search). Samuel can be reached by email at firstname.lastname@example.org or by phone at +1 (415) 738-2070.
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Netflix Inc. [LOS GATOS, Calif.] (NASDAQ: NFLX) announced that Spencer Neumann is joining the company as Chief Financial Officer. Neumann is an accomplished media and financial executive who was most recently CFO of Activision Blizzard and previously held several senior positions at the The Walt Disney Company. He succeeds David Wells who served as CFO since 2010. Neumann served as Activision Blizzard’s CFO from May 2017. Prior to that, Mr. Neumann held a number of positions of increasing responsibility at The Walt Disney Company, most recently serving as the CFO and executive vice president of Global Guest Experience of Walt Disney Parks and Resorts, from 2012 until May 2017. From 2005 to 2012, Mr. Neumann worked at the private equity firms of Providence Equity Partners and Summit Partners. Prior to that, Mr. Neumann held several other roles with Disney, which he initially joined in 1992, including executive vice president of the ABC Television Network from 2001 to 2004 and CFO of the Walt Disney Internet Group from 1999 to 2001.
Activision Blizzard, Inc. [SANTA MONICA, Calif.] (NASDAQ: ATVI) announced that Dennis Durkin has been named Chief Financial Officer, reprising the role he held from March 2012 to May 2017. Most recently, Mr. Durkin had been serving as Chief Corporate Officer for the Company. Mr. Durkin replaces Spencer Neumann who was terminated for cause for violating his legal obligations to the Company. Prior to joining the company, Mr. Durkin held a number of positions of increasing responsibility at Microsoft Corporation during an over twelve-year period.
Square, Inc. [MALVERN, Pa.] (NYSE: SQ) announced that Amrita Ahuja will join the company as Chief Financial Officer. Amrita is currently the CFO of Blizzard Entertainment and a division of Activision Blizzard. Amrita has been with Activision Blizzard for over eight years in a number of finance and strategy roles across the company, including SVP of Investor Relations, VP of Finance and Operations, and VP of Strategy and Business Development. Prior to Activision Blizzard, she held various roles at Fox Networks Group, the Walt Disney Company, and Morgan Stanley.
CIRCOR International, Inc. [BURLINGTON, Mass.] (NYSE: CIR) announced the appointment of Chadi Chahine as Senior Vice President and Chief Financial Officer. He joins CIRCOR from global medical technology company Smith & Nephew, where he was CFO of its U.S. business. Chahine joined Smith & Nephew as CFO, International Markets, in 2012. He was promoted to CFO of Smith & Nephew’s U.S. operations in February 2017. Mr. Chahine began his career in public accounting and spent 13 years at Abbott Laboratories in positions of increasing responsibility within finance and general management. In August 2018, CIRCOR announced the planned departure of CFO Rajeev Bhalla, who agreed to remain in the role until a successor was named.
Red Robin Gourmet Burgers, Inc. [GREENWOOD VILLAGE, Colo.] (NASDAQ: RRGB) announced the appointment of Lynn Schweinfurth as executive vice president and chief financial officer, effective January 28, 2019. Guy Constant, Red Robin’s current executive vice president and chief financial officer, will move to lead Company and Franchise operations, development and facilities as executive vice president and chief operating officer. Prior to joining the Company, Ms. Schweinfurth served as senior vice president, chief financial officer and treasurer of Fiesta Restaurant Group, Inc. where she has been since 2012. Prior to her time at Fiesta Restaurant Group, Inc., Ms. Schweinfurth held various senior finance leadership positions at global restaurant companies including Brinker International, Inc., Yum Brands, Inc. and PepsiCo, Inc.
Fiesta Restaurant Group, Inc. [DALLAS] (NASDAQ: FRGI), parent company of the Pollo Tropical® and Taco Cabana® fast-casual restaurant brands, announced that Lynn Schweinfurth, Chief Financial Officer, Senior Vice President, and Treasurer, has resigned effective January 25, 2019 to pursue another career opportunity. Cheri Kinder, Vice President, Corporate Controller and Chief Accounting Officer, will assume the position of Interim Chief Financial Officer and Treasurer upon the effective date of Ms. Schweinfurth’s departure.
Infogroup [OMAHA, Neb.] announced that Andy Goldstein has been named chief financial officer. Most recently he served as chief financial officer at Purch. Goldstein has also held the position of CFO for the NJ Devils, the Prudential Center Arena and Philadelphia 76ers as well as at InterMedia Outdoors Holdings, Inc., and Primedia Inc. Prior experience includes strategic finance positions at sesamestreet.com and The Times Mirror Company.
Unum Therapeutics Inc. [CAMBRIDGE, Mass.] (NASDAQ: UMRX) announced that Christiana Stamoulis, President and Chief Financial Officer, will be stepping down from the Company, effective January 31, 2019, to pursue another opportunity.
Incyte [WILMINGTON, Del.] (NASDAQ: INCY) announced the appointment of Christiana Stamoulis as Executive Vice President and Chief Financial Officer, effective February 11, 2019. Ms. Stamoulis will succeed David Gryska who, as planned, retired from Incyte at the end of 2018. Stamoulis joins Incyte from Unum Therapeutics, where she was President and Chief Financial Officer. Prior to Unum, she was the Senior Vice President of Corporate Strategy and Business Development at Vertex Pharmaceuticals. Prior to joining Vertex, she spent nearly 15 years in the investment banking and management consulting industries. She was a Managing Director at Citigroup’s Investment Banking division and prior to that, she was a senior investment banker in the Healthcare Investment Banking Group at Goldman Sachs, where she spent the majority of her investment banking career. She started her career as a strategy consultant at The Boston Consulting Group. Ms. Stamoulis serves on the Board of Directors of Hologic Inc.
Southern Company [ATLANTA] (NYSE: SO) announced that Dan Tucker will succeed Beth Reese as executive vice president and chief financial officer at Southern Company Gas. Tucker most recently served as senior vice president of finance and treasurer for Southern Company. He has been with Southern Company for more than 20 years in various roles within the finance organization, including investor relations, financial planning and accounting. In 2012, he was named vice president of investor relations and financial planning.
ImmusanT, Inc. [CAMBRIDGE, Mass.] announced the appointment of Thomas A. Shea as the company’s chief financial officer (CFO). Prior to joining ImmusanT, Mr. Shea served as CFO for a number of development stage companies, most notably Albireo Pharma, where he was integral in taking the company public via a reverse merger with Biodel in 2016; Tolerx, Inc. from 2005 to 2011; and Cubist Pharmaceuticals from 1993 to 2003.
Mellanox Technologies, Ltd. [SUNNYVALE, Calif. & YOKNEAM, Israel] (NASDAQ: MLNX) announced the appointment of Doug Ahrens as senior vice president and chief financial officer. Ahrens joins Mellanox from GlobalLogic, where he served as chief financial officer. Prior to that Mr. Ahrens served as chief financial officer of Applied Micro Circuits. His career demonstrates a strong track record of increasing financial managerial responsibilities at semiconductor companies including Maxim and Intel. He started his career as an environmental engineer at Chevron Corporation. Eric Johnson, who acted as Mellanox’s interim principal financial and accounting officer, will continue in his role as vice president and corporate controller.
Cortexyme [SOUTH SAN FRANCISCO, Calif.] announced that Chris Lowe is now the company’s Chief Financial Officer. Lowe’s 15+ years of senior management experience include experience as CFO, CBO, and CEO for private and public life sciences companies such as Asthmatx, Peninsula Pharmaceuticals, and Anthera Pharmaceuticals. In January 2014, Lowe became a partner at FLG Partners.
PRGX Global, Inc. [ATLANTA] (NASDAQ: PRGX) announced that it appointed Kurt Abkemeier as Chief Financial Officer, Treasurer and Controller. Peter Limeri, who has been serving as the interim Chief Financial Officer, Treasurer and Controller, will remain with the Company until the end of the month. Abkemeier joins PRGX from Fidelis Cybersecurity, Inc., where he served as Chief Financial Officer. Prior to Fidelis, Mr. Abkemeier served as Chief Financial Officer for Progress Software, Inc. Abkemeier previously held senior finance roles at a number of other publicly traded companies, including Inteliquent, Inc., where he was Chief Financial Officer, Cbeyond, Inc. and Airgate PCS, Inc. Mr. Abkemeier started his career at JP Morgan.
Marlin Business Services Corp. [MOUNT LAUREL, N.J.] (NASDAQ: MRLN) announced that it has named Michael R. Bogansky as Senior Vice President and Chief Financial Officer effective on February 1, 2019. Bogansky joins Marlin from PHH Corporation where he was most recently Senior Vice President and Chief Financial Officer. PHH was recently acquired by Ocwen Financial Corporation. Prior to that, he was Senior Vice President, Corporate Controller & Principal Accounting Officer of PHH. Before joining PHH in 2003, Mr. Bogansky was a Senior Audit Associate with Deloitte & Touche, LLP.
Lattice Semiconductor Corporation [PORTLAND, Ore.] (NASDAQ: LSCC) announced the appointment of Sherri Luther as the Company’s Chief Financial Officer. Prior to Lattice, Ms. Luther was Corporate Vice President of Finance at Coherent Inc. Prior to Coherent, Ms. Luther held a number of senior finance and accounting positions at companies including Quantum, Ultra Network Technologies and Arthur Andersen.
BlueCrest [DANBURY, Conn.] announced the appointment of Paul Kosturos as Interim Chief Financial Officer. Kosturos will replace former BlueCrest CFO Ray Altieri, who retired at the end of 2018, as Interim CFO. Kosturos is a Senior Director with Alvarez & Marsal’s Private Equity Performance Improvement Group, LLC and brings more than 30 years of experience to the role.
TELA Bio®, Inc. [MALVERN, Pa.] announced that Nora Brennan has joined the company as chief financial officer. Prior to joining TELA Bio, Ms. Brennan served as the chief financial officer at Xeris Pharmaceuticals, Inc. Prior to Xeris, she was employed at Integra Lifesciences Corporation, where she held various senior leadership roles, including Senior Vice President, Investor Relations and Corporate Treasurer.
Fortis Energy Services, Inc. [TROY, MICH.] announced the promotion of Susan Censoni to Chief Financial Officer. Mrs. Censoni has over twenty years of experience in both the private sector and in public accounting and has served as the VP Finance since joining Fortis in March 2013. Prior to joining Fortis, she was a Senior Manager at KPMG LLP.
InnerWorkings, Inc. [CHICAGO] (NASDAQ: INWK) announced that Donald W. Pearson has been appointed Executive Vice President and Chief Financial Officer. Most recently, Pearson served as Chief Financial Officer of BWAY Corporation, before its sale to Stone Canyon Industries. Prior to BWAY, Mr. Pearson was Chief Financial Officer of AMCOL International Corporation and later Chief Financial Officer of Sparton Corporation. Mr. Pearson will replace interim Chief Financial Officer, Chip Hodgkins.
TILT Holdings Inc. [CAMBRIDGE, Mass.] (CSE: TILT, OTC: SVVTF) announced the appointment of David Caloia as Chief Financial Officer. Mr. Caloia joins TILT having spent the first 16 years of his career at GE in finance and operations. While there, he maintained leadership positions in finance across the globe, the last as the CFO of GE Industrial Solutions. Prior to joining TILT, David was the Senior Vice President, Financial Planning & Analysis of Beacon Health Options.
Diebold Nixdorf [NORTH CANTON, Ohio] (NYSE: DBD) announced that Jeffrey Rutherford, who recently joined the company as interim chief financial officer, will now fill that position on a permanent basis. Rutherford joined the company from Edgewater Technology. Prior to Edgewater, he held the chief financial officer position at a number of companies, including Ferro Corporation, Park-Ohio Holdings Corp, UAP Holding, LESCO and Office Max.
Unitil Corporation [HAMPTON, N.H.] (NYSE: UTL) announced the planned retirement of Mark H. Collin, Senior Vice President, Chief Financial Officer and Treasurer, effective May 1, 2019. Mr. Collin has served as Unitil’s corporate Treasurer since 1998 and has been the Chief Financial Officer since 2003. Unitil announced the hiring of Christine L. Vaughan as Senior Vice President, Financial and Regulatory Services, effective January 2, 2019, as Mr. Collin’s planned successor. As part of Unitil’s long term succession plan, Mr. Collin will formally step down as Chief Financial Officer and Treasurer on March 1, 2019, and will work with Ms. Vaughan in order to assure a smooth transition period prior to his retirement. Ms. Vaughan will assume the title of Senior Vice President, Chief Financial Officer and Treasurer of the Company on March 1, 2019. Ms. Vaughan most recently served as Vice President, Rates and Regulatory and Treasurer for Eversource Energy in Massachusetts, where she had been employed since 2004. Ms. Vaughan previously worked as a management consultant at Arthur D. Little and an engineer at DuPont and BASF.
REVA Medical, Inc. [SAN DIEGO] (ASX: RVA) announced the promotion of Leigh Elkolli to the position of Chief Financial Officer and Corporate Secretary. She will replace Brandi Roberts, who served as REVA’s Chief Financial Officer and Corporate Secretary since August 2017 until her resignation effective January 4, 2019. Ms. Elkolli joined REVA in August 2017 as Senior Director of Finance and Corporate Controller. Elkolli joined REVA from Avidity Biosciences, where she was Director of Finance. Ms. Elkolli started her career with Ernst & Young where she spent seven years in their assurance services practice serving public and private clients in the life science and technologies industries.
Bio-Rad Laboratories, Inc. [HERCULES, Calif.] (NYSE: BIO) announced that Christine A. Tsingos has informed the company of her intention to retire as Executive Vice President and Chief Financial Officer effective April 30, 2019. Ms. Tsingos will remain in her current role through April 30 and will assist in the orderly transition to a successor.
Calyxt, Inc. [MINNEAPOLIS & ST. PAUL, Minn.] (NASDAQ: CLXT) announced the hiring of William F. (Bill) Koschak, as Chief Financial Officer of Calyxt, effective January 7, 2019. Mr. Koschak will be assuming the responsibilities of current interim CFO, Eric Dutang, who remains CFO of Cellectis, Calyxt’s parent company. Most recently, Koschak was Vice President, Finance for the Brain Therapies business unit of Medtronic and also served as Interim Vice President, General Manager, for one of the units of Brain Therapies for several months. Prior to Medtronic, Mr. Koschak also held executive positions at Young America Holdings, where he was CFO, General Mills, and KPMG LLP.
Livongo Health [MOUNTAIN VIEW, Calif.] announced that it named Lee Shapiro Chief Financial Officer. Shapiro, who has been on the Board of Livongo since its founding and served as Chair of its Audit Committee, will take his new role in February 2019. Shapiro currently serves on the Board and as member of the audit committee of Medidata Solutions and is the Chairman of the Audit Committee of Tivity Health. He previously served as President of Allscripts Healthcare Solutions from 2001-2012. Subsequently, he co-founded 7wireVentures. Shapiro is Managing Partner of the 7wireVentures Connected Consumer Fund and has served on the boards of many of its portfolio companies.
IGM Biosciences, Inc. [MOUNTAIN VIEW, Calif.] announced the appointment of Misbah Tahir to the newly created position of Chief Financial Officer. Most recently, Mr. Tahir was Vice President, Head of Finance at Dermira, Inc. Prior to his role at Dermira, Mr. Tahir was Director, Head of Commercial Financial Planning and Analysis at Onyx Pharmaceuticals, Inc. Before that, he was Associate Director of Revenue at Human Genome Sciences, Inc. (HGS) and was Chair of the HGS-GlaxoSmithKline Joint Finance Committee. Prior to HGS, Mr. Tahir spent six years at Amgen, Inc. in finance and accounting management roles. He began his professional career at the global management consulting firm Oliver Wyman.
AAR [WOOD DALE, Ill.] (NYSE: AIR) announced that it has appointed Sean Gillen as Vice President and Chief Financial Officer. Mr. Gillen will succeed Michael Milligan. Gillen joins AAR from USG Corporation where he served as Vice President and Treasurer. Prior to USG, Mr. Gillen spent nine years in investment banking with Goldman Sachs in their Global Industrials Group.
Matinas BioPharma Holdings, Inc. [BEDMINSTER, N.J.] (NYSE AMER: MTNB) announced that it has appointed Keith A. Kucinski as Chief Financial Officer. Kucinski joins Matinas BioPharma having most recently served as Chief Financial Officer at RemedyOne. Prior to that, he served as Vice President & Treasurer at Par Pharmaceutical Companies, Inc., an operating company of Endo International plc. Additionally, Mr. Kucinski held various roles at Barr Pharmaceuticals, Inc., including Senior Director, Finance & Corporate Development and Assistant Treasurer & Senior Director, Finance.
Pliant Therapeutics, Inc. [SAN FRANCISCO] announced that Keith Cummings joined the company as chief financial officer. Dr. Cummings joins Pliant from Citigroup Global Markets where he served as a director in the Investment Banking Healthcare Group. Prior to Citigroup, he worked as an investment banker at Lehman Brothers and Barclays in New York.
Arcturus Therapeutics Ltd. [SAN DIEGO] (NASDAQ: ARCT) announced that the Company has appointed Andrew Sassine as Chief Financial Officer (CFO). Mr. Sassine has been serving as Arcturus’ Interim Chief Financial Officer since August 2018 and has served on the Company’s Board of Directors since May 2018. In addition to serving on the Arcturus board, Mr. Sassine serves on the boards of iCAD, Inc. and Gemphire Therapeutics . Previously, Mr. Sassine served in various positions at Fidelity Investments from 1999 to 2012, most recently as portfolio manager.